fda glp-1 safety alert october 2025 GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Compounded weight-loss and hormone drugs

2016, Mediators of Inflammation

Most people can get right back to their day after the treatment is over, without any side effects or post-treatment problems

Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella IL

Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinsons disease

With this blend of routine and care, its no wonder their glow is truly enviable

Several GLP-1RAs, including exenatide, dulaglutide, semaglutide, and liraglutide, are approved for T2D, alongside tirzepatide, which also acts on glucose-dependent insulinotropic polypeptide (GIP) receptors